Ardent Health (ARDT) Cash from Financing Activities (2023 - 2026)

Ardent Health's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at -$11.8 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 14.79% year-over-year to -$11.8 million; the TTM figure through Mar 2026 stood at -$101.4 million (down 446.21% YoY), while the FY2025 annual figure was -$103.5 million, down 519.87% from the prior year.
• Cash from Financing Activities was -$11.8 million for Q1 2026 at Ardent Health, up from -$37.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $183.4 million in Q3 2024 to a low of -$119.8 million in Q2 2024.
• Historically, Cash from Financing Activities has averaged -$12.0 million across 4 years, with a median of -$20.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 867.13% in 2024, then plunged 114.68% in 2025.
• A 4-year view of Cash from Financing Activities shows it stood at -$17.9 million in 2023, then retreated by 14.48% to -$20.5 million in 2024, then slumped by 80.88% to -$37.0 million in 2025, then jumped by 68.19% to -$11.8 million in 2026.
• The last three Cash from Financing Activities figures came in at -$11.8 million (Q1 2026), -$37.0 million (Q4 2025), and -$26.9 million (Q3 2025), per Business Quant data.